Ares Management Faces Q3 Print with Analysts Trimming Targets

ARES reports third-quarter results on October 29 having recovered sharply from a difficult month, with the stock up 8.7% over the past week to $122.08 after sliding 2.1% over the prior 30 days.

The week's bounce was broad across the alternative asset manager peer group, but ARES kept pace. BX gained 10.7% and CG added 6.1% over the same stretch, while KKR and OWL rose roughly 6% and 5.8% respectively. ARES was neither the strongest nor the weakest in the group, a change from a recent stretch of underperformance in which the stock fell 22.8% year-to-date against a more resilient peer set. At $122.08, it trades at a 16% discount to the analyst consensus target of $144.90, which was struck as recently as October 23. Short interest is 7% of free float, roughly 15.3 million shares, and has drifted lower over the past month, down about 8% from September levels. Borrow remains easy: availability is 301%, meaning there are roughly three shares available to lend for every share already borrowed, and the cost to borrow has fallen to 0.46%, its lowest level in six weeks. Options positioning is elevated but only modestly so. The put/call ratio of 2.49 is close to its 20-day average of 2.44 and well below the 52-week high of 2.90, placing no particular weight on directional bets into the print.

The analyst debate is less about growth potential and more about execution. The bull case rests on Ares's $671.3 billion of total AUM, strong institutional fundraising, and management's stated target of 16% to 20% fee-related earnings CAGR through 2028, with credit and real assets improving deployment. The bear case points directly at the Q1 report, where after-tax realized net income came in at $1.24 per share against a $1.37 estimate, and FRE of $1.33 missed the $1.43 estimate, with shortfalls in both performance fees and base management fees. Analysts have largely kept their ratings intact but trimmed price targets in the run-up: Piper Sandler cut to $143 from $150 on October 19, UBS moved to $134 from $142 on October 13, and TD Cowen reduced to $159 from $163 on October 12. The direction of travel in analyst estimates is downward even where conviction on the long-term thesis remains.

The ownership picture adds some weight to the fundamental backdrop. BlackRock reported a holding of 16.9 million shares, or 7.4% of the company, as of September 30, adding 713,000 shares in the period. State Street added 817,000 shares in the same quarter. T. Rowe Price stands out more: it reported 4.8 million shares as of September 30, a reported change of 3.4 million shares, indicating a substantial addition. Founder and co-chairman Antony Ressler holds 33.1% of the company as of his most recent 13G/A filing in August, down slightly from 34.2% previously. Recent insider activity carries little signal: the only Form 4 transactions since late June are tax-withholding filings (transaction code F) and director equity grants, neither of which reflects discretionary conviction. No activist 13D holders are on the register.

The October 29 print will test whether the Q1 miss in management fees and performance fees was a one-quarter anomaly or the start of a more persistent shortfall in the earnings trajectory that underpins the long-term FRE growth case.